Lataa...
Mammospheres of letrozole-resistant breast cancer cells enhance breast cancer aggressiveness
Aromatase inhibitors (AIs), such as letrozole, are considered as first-line treatment for estrogen receptor-positive breast cancer in postmenopausal women. Despite the successful use of letrozole, resistance to therapy, tumor relapse and metastasis remain principal causes of patient mortality. Altho...
Tallennettuna:
| Julkaisussa: | Oncol Lett |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
D.A. Spandidos
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8258623/ https://ncbi.nlm.nih.gov/pubmed/34267813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2021.12881 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|